Overview A leading provider of cancer screening and diagnostic tests, Exact Sciences Corporation (together with its subsidiaries, Exact, we, us, our or the Company) gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard and Oncotype DX tests, we are investing in our pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. During 2025, we achieved many milestones, includin...
Q2 FY2026 — expected 2026-08-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001124140-26-000011 | EDGAR | 111K words |
| 2025-02-19 | 2024-12-31 | 0001124140-25-000020 | EDGAR | — |
| 2024-02-21 | 2023-12-31 | 0001124140-24-000012 | EDGAR | — |
| 2023-02-21 | 2022-12-31 | 0001124140-23-000014 | EDGAR | — |
| 2022-02-22 | 2021-12-31 | 0001124140-22-000022 | EDGAR | — |
| 2021-02-16 | 2020-12-31 | 0001124140-21-000029 | EDGAR | — |
| 2020-02-21 | 2019-12-31 | 0001124140-20-000010 | EDGAR | — |
| 2019-02-21 | 2018-12-31 | 0001558370-19-000854 | EDGAR | — |
| 2018-02-22 | 2017-12-31 | 0001558370-18-000941 | EDGAR | — |
| 2017-02-21 | 2016-12-31 | 0001558370-17-000714 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-03 | 2025-09-30 | 0001124140-25-000091 | EDGAR | 27K words |
| 2025-08-06 | 2025-06-30 | 0001124140-25-000083 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0001124140-25-000043 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0001124140-24-000083 | EDGAR | — |
| 2024-07-31 | 2024-06-30 | 0001124140-24-000069 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001124140-24-000046 | EDGAR | — |
| 2023-11-01 | 2023-09-30 | 0001124140-23-000090 | EDGAR | — |
| 2023-08-01 | 2023-06-30 | 0001124140-23-000082 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001124140-23-000044 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001124140-22-000071 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001124140-22-000061 | EDGAR | — |
| 2022-04-26 | 2022-03-31 | 0001124140-22-000030 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-23 | 0001193125-26-118700 | EDGAR | 2K words |
| 2026-03-20 | 0001193125-26-116862 | EDGAR | — |
| 2026-02-20 | 0001193125-26-061570 | EDGAR | — |
| 2026-02-13 | 0001124140-26-000010 | EDGAR | — |
| 2026-02-10 | 0001193125-26-044657 | EDGAR | — |
| 2025-12-29 | 0001193125-25-332352 | EDGAR | — |
| 2025-11-20 | 0001193125-25-288896 | EDGAR | — |
| 2025-11-03 | 0001124140-25-000090 | EDGAR | — |
| 2025-08-06 | 0001124140-25-000081 | EDGAR | — |
| 2025-06-16 | 0001124140-25-000046 | EDGAR | — |
177 total filings indexed. 145 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001124140 |
| Ticker | EXAS |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report